- Report
- January 2026
- 187 Pages
Global
From €3436EUR$3,939USD£2,994GBP
- Report
- August 2025
- 195 Pages
Global
From €3436EUR$3,939USD£2,994GBP
- Report
- January 2026
- 185 Pages
Global
From €3925EUR$4,500USD£3,421GBP
- Report
- July 2025
- 175 Pages
Global
From €3916EUR$4,490USD£3,413GBP
- Report
- April 2025
- 175 Pages
Global
From €3916EUR$4,490USD£3,413GBP
- Report
- February 2026
- 152 Pages
Global
From €5103EUR$5,850USD£4,447GBP
- Report
- September 2025
- 150 Pages
Global
From €3358EUR$3,850USD£2,927GBP
€4230EUR$4,850USD£3,687GBP
- Report
- March 2025
- 309 Pages
Global
From €3924EUR$4,499USD£3,420GBP
- Report
- May 2025
- 560 Pages
Global
From €4318EUR$4,950USD£3,763GBP
- Report
- September 2025
- 100 Pages
Global
From €4274EUR$4,900USD£3,725GBP
- Report
- August 2025
- 150 Pages
Global
From €5190EUR$5,950USD£4,523GBP
- Report
- October 2025
- 150 Pages
Global
From €5190EUR$5,950USD£4,523GBP
- Report
- June 2025
- 150 Pages
Global
From €5190EUR$5,950USD£4,523GBP
- Report
- September 2025
- 150 Pages
Global
From €3488EUR$3,999USD£3,040GBP
- Report
- April 2025
- 138 Pages
Global
From €3488EUR$3,999USD£3,040GBP
- Report
- May 2025
- 200 Pages
Global
From €2172EUR$2,490USD£1,893GBP
- Report
- October 2025
- 150 Pages
Global
From €5190EUR$5,950USD£4,523GBP
- Report
- April 2025
- 120 Pages
Global
From €5190EUR$5,950USD£4,523GBP
- Report
- January 2026
- 326 Pages
Global
From €3925EUR$4,500USD£3,421GBP
- Report
- February 2026
- 278 Pages
Global
From €5103EUR$5,850USD£4,447GBP

A diagnostic biomarker is a biological molecule or gene that is used to identify a particular disease or condition. It is used to diagnose, monitor, and predict the progression of a disease or condition. Diagnostic biomarkers are used to detect the presence of a disease or condition, to determine the severity of the disease or condition, and to monitor the effectiveness of treatments. Diagnostic biomarkers are used in a variety of medical fields, including oncology, neurology, cardiology, and infectious diseases.
Diagnostic biomarkers are typically identified through a variety of methods, including genetic sequencing, proteomics, and metabolomics. These methods allow for the identification of biomarkers that are specific to a particular disease or condition.
The diagnostic biomarker market is a rapidly growing field, with many companies developing and marketing diagnostic biomarkers. Companies in this market include Illumina, Thermo Fisher Scientific, Qiagen, Roche, and Agilent Technologies. Show Less Read more